Bayesian Capital Management, LP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 199 filers reported holding TRANSMEDICS GROUP INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$1,118,816
+84.1%
20,435
+182.4%
0.13%
+96.9%
Q2 2023$607,595
-20.0%
7,235
-27.9%
0.06%
-30.9%
Q1 2023$759,951
+34.8%
10,035
+9.9%
0.09%
+14.6%
Q4 2022$563,8129,1350.08%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2022
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders